Video Abstract

Video Abstract

Close modal
BACKGROUND

Multiple systematic reviews examine the introduction of foods in relation to individual health outcomes, but the balance of harms and benefits has not been overviewed systematically.

OBJECTIVES

We aimed to perform an overview of systematic reviews on age of introduction of complementary and allergenic foods to the infant diet and long and short-term health outcomes.

DATA SOURCES

We searched Medline, Embase, Cochrane, and PubMed (July 25, 2022).

STUDY SELECTION

Included systematic reviews examining the introduction of complementary or allergenic foods before age 1. Outcomes included allergic, autoimmune, and inflammatory diseases, neurodevelopment, nutrition, and weight.

DATA EXTRACTION

Extraction and quality assessment were performed in duplicate (A Measurement Tool to Assess Systematic Reviews) and strength of evidence was assessed.

RESULTS

We screened 4015 articles and included 32 systematic reviews. There was moderate evidence that peanut and egg should be introduced from 4 to 11 months to prevent food allergy (6 of 10 reviews). Complementary food introduction was not associated with food allergy. Moderate certainty evidence suggested age of complementary food introduction was not associated with eczema. Age at introduction of gluten was not associated with celiac disease (high certainty evidence; 3 of 4 reviews). Low certainty evidence indicated that introducing solids before 4 months may increase the risk of childhood obesity, but not growth. There was insufficient evidence regarding an association between any food introduction and bone health, gastrointestinal diseases, autoimmune disorders, asthma, or allergic rhinitis.

LIMITATIONS

Gray literature was not included.

CONCLUSIONS

Current evidence supports introducing complementary foods around 6 months and allergenic foods before 11 months.

Infant and child nutrition is key for healthy cognitive and physical development. Inappropriate infant feeding practices lead to malnutrition, morbidity, and mortality. Breastfeeding is known to protect both mother and child against a series of health outcomes.13  Increasing breastfeeding could have prevented up to 823 000 child deaths under 5 years old in 75 high-mortality lower-middle income countries in 2015 alone.3  Nevertheless, breastfeeding and infant formula no longer provide all the nutrients a growing infant requires to stay healthy after around 6 months of age.4  Infants’ renal and gastrointestinal systems can metabolize complementary foods from 4 months onwards.5  Motor and dental development sufficient to chew and swallow foods may develop later around 6 months.5  United Nations Children’s Fund recommends feeding a 6 to 8 month infant “half a cup of soft food 2 to 3 times a day” with an iron rich diet.6  During this transition from a liquid to solid diet, infants are susceptible to infection and malnutrition.7,8  For example, 20% of 6- to 11-month-old infants in the United States are considered iron deficient.8  Poor quality diets are a risk factor for noncommunicable diseases.9,10  These diseases include obesity, cardiovascular disease, autoimmune disorders, and allergic disease. Food allergy is among those recognized as an important public health problem around the world.

Food introduction guidelines commonly separate their advice by general complementary food and potentially allergenic foods.11  Complementary food is defined as all solid and liquid foods other than breast milk or infant formula12  by all the following guidelines except the World Health Organization (WHO). The WHO 2003 guidelines recommend introducing complementary foods, deemed any food or drink except breastmilk, from 6 months onwards while continuing to breastfeed.7  United States and Australian infant feeding guidelines recommend introducing complementary foods at around 6 months of age.13,14  The European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (2017) recommends they “not be introduced before 4 months”, nor “delayed past 6 months.”12  The society based these recommendations on original articles and systematic reviews; however, their methodology was lacking a systematic approach.

The 2003 WHO, 2013 Australian, and 2017 European complementary feeding infant guidelines above have not yet been updated to specify when to introduce allergenic solids. The United States, Australia, and Europe have specific infant feeding guidelines targeting food allergy prevention by recommending the introduction of allergenic solids in the first year of life.1517  Age at introduction of allergenic foods may have an impact on a range of health outcomes unrelated to food allergy, which will be explored here.

Consistent weaning advice is essential. Guidelines need to carefully balance the wide range of health outcomes that may be associated with timing of introduction of complementary and allergenic foods. Multiple systematic reviews examine the introduction of foods in relation to individual health outcomes, but the balance of harms and benefits of these exposures on all health outcomes for children has not been overviewed in a systematic and peer-reviewed manner. Such an overview is urgently required to inform policy and guidelines on food introduction in infants, as well as reassure parents and physicians as to the most up-to-date research available. Hence, we aimed to overview previous systematic reviews to consolidate the evidence on the short and long-term health outcomes of timing of introduction of general and allergenic complementary foods in infants.

The protocol was created based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2015 checklist.18  Reporting has been checked using the Preferred Reporting Items for Overviews of Systematic Reviews with harms 2017 checklist.19  The protocol was published previously on PROSPERO (CRD42020158525). Significant protocol amendments have been explained.

We included systematic reviews of human participants that reported age of first introduction of complementary or allergenic food by age 1 and outcomes after and including age 1. A systematic review was defined as in the Cochrane handbook,20  with full compliance assessed in the quality assessment. Complementary food was defined as any solid, semisolid, or soft food, excluding breastmilk, infant formula, supplements, vitamins, or water. Allergenic foods included peanuts, hen’s egg, cow’s milk (not including through introduction of infant formula), shellfish, tree nuts, soybean, and wheat. Outcomes included common noncommunicable diseases, which could plausibly be affected by diet including allergic, inflammatory, and autoimmune diseases, and growth and nutritional outcomes (Table 1). Narrative reviews, original studies, breastmilk or formula exposures, and nonpeer review literature were excluded. The full inclusion and exclusion criteria is presented in Table 1.

TABLE 1

Inclusion and Exclusion Criteria for Included Systematic Reviews

CategoryInclusion CriteriaExclusion Criteria
Study design Systematic reviewsa Narrative reviews 
 Meta-analyses Original studies (intervention or observational designs) 
Population of interest Human participants of any age. Animal studies 
Age of participants Age at intervention or exposure: 0 to 12 mo of age Age at intervention or exposure: age 1 y and over 
 Age at outcome: from 12 mo onwards (no maximum age) Age at outcome: 0 to 11 mo 
 Studies that include a broader age range were included and the data within the relevant age range was extracted.  
Intervention or exposure Age of complementary food introduction, defined as any solid, semisolid, or soft food. Breastmilk, infant formula (including cow’s milk in infant formula), supplements, vitamins, or water. 
 Age of allergenic food introduction including, but not limited to, peanuts, hen’s egg, cow’s milk, shellfish, tree nuts, soybean, and wheat.  
Comparator Different age of introduction of complementary or allergenic food.  
Outcomes Incidence or prevalence of: No restrictions 
(Dependent variable) Allergic diseases: food allergy or hypersensitivity, eosinophilic esophagitis, asthma or wheeze, eczema or atopic dermatitis, allergic rhinitis.  
 Autoimmune disease: diabetes type 1, celiac disease, pernicious anemia.  
 Nutrition: obesity or overweight, body wt, thinness, diabetes type 2, iron deficiency or anemia, dental caries.  
 Other diseases: cardiovascular disease, respiratory tract infection, neurodevelopment, diarrhea.  
Date range Studies published from inception to July 25, 2022 No restrictions 
Language Any language No restrictions 
Publication status Studies published in peer-reviewed scientific journals Gray literature (Not peer-reviewed), including book chapters and conference abstracts 
Health status Any health status, including preterm infants, and populations restricted to high risk populations (eg, high risk of allergy or obesity). No restrictions 
CategoryInclusion CriteriaExclusion Criteria
Study design Systematic reviewsa Narrative reviews 
 Meta-analyses Original studies (intervention or observational designs) 
Population of interest Human participants of any age. Animal studies 
Age of participants Age at intervention or exposure: 0 to 12 mo of age Age at intervention or exposure: age 1 y and over 
 Age at outcome: from 12 mo onwards (no maximum age) Age at outcome: 0 to 11 mo 
 Studies that include a broader age range were included and the data within the relevant age range was extracted.  
Intervention or exposure Age of complementary food introduction, defined as any solid, semisolid, or soft food. Breastmilk, infant formula (including cow’s milk in infant formula), supplements, vitamins, or water. 
 Age of allergenic food introduction including, but not limited to, peanuts, hen’s egg, cow’s milk, shellfish, tree nuts, soybean, and wheat.  
Comparator Different age of introduction of complementary or allergenic food.  
Outcomes Incidence or prevalence of: No restrictions 
(Dependent variable) Allergic diseases: food allergy or hypersensitivity, eosinophilic esophagitis, asthma or wheeze, eczema or atopic dermatitis, allergic rhinitis.  
 Autoimmune disease: diabetes type 1, celiac disease, pernicious anemia.  
 Nutrition: obesity or overweight, body wt, thinness, diabetes type 2, iron deficiency or anemia, dental caries.  
 Other diseases: cardiovascular disease, respiratory tract infection, neurodevelopment, diarrhea.  
Date range Studies published from inception to July 25, 2022 No restrictions 
Language Any language No restrictions 
Publication status Studies published in peer-reviewed scientific journals Gray literature (Not peer-reviewed), including book chapters and conference abstracts 
Health status Any health status, including preterm infants, and populations restricted to high risk populations (eg, high risk of allergy or obesity). No restrictions 
a

A systematic review was defined as in the Cochrane handbook.20 

We searched Medline, Embase, Cochrane Database of Systematic Reviews, and the last 24 months of PubMed to capture reviews not yet available in Medline, from inception to July 25, 2022 (Supplemental Table 4). We included systematic reviews in any language. Reference lists of included studies were hand-checked to ensure we did not miss key reviews. Conference abstracts were checked to see if results had been published in paper form. Duplicates were removed using Endnote X8. A librarian and expert on the topic helped create the search strategy. Additional primary studies were not included but were discussed where appropriate in the discussion.

Article screening and extraction was performed in duplicate. Two independent reviewers screened titles and abstracts (V.X.S. and D.C., Y.W., or G.G.) and read selected full texts for eligibility (V.X.S. and D.C.). Conflicts were resolved by discussion or a third reviewer (J.J.K.). The title and abstract screening checklist is in Supplemental Table 5 and full texts were assessed as per the inclusion and exclusion criteria in Table 1. We piloted the selection process with 50 titles and abstracts, 10 full texts, and 2 extractions and quality assessments. Extraction was conducted using the form in Supplemental Figure 4. Agreement was measured using random agreement probability and Cohen’s κ.

Two independent reviewers (V.X.S. and D.C. or Y.W.) appraised the quality and risk of bias of systematic reviews using the A Measurement Tool to Assess Systematic Reviews (AMSTAR 2) tool (2017).21  AMSTAR 2 evaluates the overall confidence in reviews as high, moderate, low, or very low, according to critical domains (Supplemental Methods). Low and very low confidence reviews may not present an accurate or comprehensive summary of the data. Reviews were included regardless of quality. Where strength of evidence was not assessed with Grading of Recommendations Assessment, Development, and Evaluation (GRADE) as part of the original systematic review, we performed our own GRADE assessment using the information available within the review to assist with between-review outcome comparisons (Supplemental Methods, Supplemental Fig 5). Heterogeneity (I2) and selection bias outcomes were extracted in duplicate where available.

Results were grouped by health outcome and presented in a narrative manner as decided a priori because of expected heterogeneity of results and according to recommendations in the Cochrane Handbook.20  We had planned to separate outcomes by region of the world; this was not possible as few systematic reviews distinguished regions. All reviews were presented even if primary studies within the reviews overlapped. Overlap of primary studies presented in multiple reviews was documented. Where data were missing, authors were contacted to obtain further information. Covidence was used to manage articles, screen, and extract data. The statistical software package Stata (release 17.0; StataCorp, Tx) for data analysis.

We identified 8427 records, of which 4015 title and abstracts and 156 full texts were screened in duplicate (Fig 1). We included 32 systematic reviews for extraction and qualitative synthesis. The reviewers had good agreement both for the title and abstract screening (95%) and full-text review (95%; Supplemental Table 6). A list of the 124 excluded full texts and exclusion reasons are in Supplemental Table 7. In total, 410 index publications (the first occurrence of a primary publication in the included reviews) were included in the 32 reviews. Overlap of primary studies presented in multiple reviews and number of duplicate articles (articles also published in another review) are available in Supplemental Table 8.

FIGURE 1

(a) Index publication is the first occurrence of a primary publication in the included review

FIGURE 1

(a) Index publication is the first occurrence of a primary publication in the included review

Close modal

Characteristics of the 32 reviews can be found in Table 2. Twenty-two reviews included both randomized controlled trial (RCT) and observational study designs. Observational study design were commonly included because of the lack of published intervention trials. Most reviews (n = 19) included age of introduction of complementary food as an exposure of interest. The review by Vissers 201822  was the only one focused solely on studies of preterm infants. Medline, PubMed, Embase, and Cochrane were among the most common databases searched by included reviews. Further details can be found in Supplemental Table 9 and 10.

TABLE 2

Summary of Characteristics of the 32 Included Systematic Reviews

CharacteristicsCategoryN%References
Study design Both RCT and observational 22 73.3 2228,3134,36,37,4145,5053  
 RCTs only 10.0 29,35,49  
 Observational only 23.3 30,3840,4648  
Intervention or exposure Complementary and allergenic solidsa 16.7 25,29,31,36,50  
Complementary food 14 46.7 2224,26,27,30,33,37,40,42,44,4648  
Allergenic solidsa 10.0 28,34,35  
 Peanut 3.3 45  
 Egg 3.3 49  
 Fish 3.3 38  
 Wheat or gluten 16.7 41,43,5153  
 Cow’s milk 6.7 32,39  
Language English only 17 56.7 2327,31,33,34,3640,4345,48  
 English and others 10.0 22,32,35  
 No restriction 30.0 2830,41,4953  
 Not specified 10.0 42,46,47  
Overall confidence (AMSTAR 2) High 23.3 2329  
Moderate 16.7 4953  
 Low 26.7 22,30,31,3638,41,43  
 Very low 12 40.0 3235,39,40,42,4448  
Potential conflicts of interest Yes 6.7 33,52  
Maybe 3.3 50  
 No 29 96.7 2232,3449,51,53  
CharacteristicsCategoryN%References
Study design Both RCT and observational 22 73.3 2228,3134,36,37,4145,5053  
 RCTs only 10.0 29,35,49  
 Observational only 23.3 30,3840,4648  
Intervention or exposure Complementary and allergenic solidsa 16.7 25,29,31,36,50  
Complementary food 14 46.7 2224,26,27,30,33,37,40,42,44,4648  
Allergenic solidsa 10.0 28,34,35  
 Peanut 3.3 45  
 Egg 3.3 49  
 Fish 3.3 38  
 Wheat or gluten 16.7 41,43,5153  
 Cow’s milk 6.7 32,39  
Language English only 17 56.7 2327,31,33,34,3640,4345,48  
 English and others 10.0 22,32,35  
 No restriction 30.0 2830,41,4953  
 Not specified 10.0 42,46,47  
Overall confidence (AMSTAR 2) High 23.3 2329  
Moderate 16.7 4953  
 Low 26.7 22,30,31,3638,41,43  
 Very low 12 40.0 3235,39,40,42,4448  
Potential conflicts of interest Yes 6.7 33,52  
Maybe 3.3 50  
 No 29 96.7 2232,3449,51,53  

RCT, randomized controlled trial.

a

Reviewed the literature on allergenic solids, both individual foods and/or as a group.

The AMSTAR 2 ratings of included systematic reviews are shown in Fig 2, with further details in Supplemental Table 10. Of the 32 included reviews, 7 were high quality (only 1 noncritical weakness each).2329  English 2019a,b24,27  and Obbagy 2019a,b,c23,25,26  did not explicitly justify their restriction to English language only searches. Ierodiakonou 201628  did not provide a list of the studies they excluded. De Silva 202029  only provided basic details on their inclusion criteria, but not extensive details. We have low to very low confidence that 20 of the 32 reviews accurately and objectively summarize the literature in question.22,3048 

FIGURE 2

Full AMSTAR 2 ratings of included systematic reviews. Key: green check, complies with all the required criteria; yellow circle, complies with basic criteria only; red cross, does not comply with the basic criteria; white circle, not applicable to this review. Summary of AMSTAR questions: (1) Described inclusion criteria? (2) Protocol or method reported? (3) Study design selection explained? (4) Search strategy? (5–6) Study selection and extraction in duplicate? (7) List of excluded studies? (8) Study descriptions adequate? (9) Risk of bias evaluated? (10) Funding source for included studies? (11) Meta-analysis: statistical methods appropriate? (12) Meta-analysis: risk of bias? (13) Risk of bias discussed? (14) Heterogeneity discussed? (15) Meta-analysis: publication bias assessed and discuss? (16) Author conflict of interest? RCT, randomized controlled trial; Obs, observational study.

FIGURE 2

Full AMSTAR 2 ratings of included systematic reviews. Key: green check, complies with all the required criteria; yellow circle, complies with basic criteria only; red cross, does not comply with the basic criteria; white circle, not applicable to this review. Summary of AMSTAR questions: (1) Described inclusion criteria? (2) Protocol or method reported? (3) Study design selection explained? (4) Search strategy? (5–6) Study selection and extraction in duplicate? (7) List of excluded studies? (8) Study descriptions adequate? (9) Risk of bias evaluated? (10) Funding source for included studies? (11) Meta-analysis: statistical methods appropriate? (12) Meta-analysis: risk of bias? (13) Risk of bias discussed? (14) Heterogeneity discussed? (15) Meta-analysis: publication bias assessed and discuss? (16) Author conflict of interest? RCT, randomized controlled trial; Obs, observational study.

Close modal

About half of the reviews contained detailed, publicly available protocols established before the review (question #2).2231,4953  Two of those did not specify their meta-analysis plans or plans to investigate heterogeneity.31,50  Only 7 reviews used a comprehensive literature search strategy (question #4), which was unlikely to be biased.28,29,38,41,46,50,53 

Sixteen of the 22 reviews including all study designs assessed the risk of bias adequately in all study designs (question #9).2228,32,36,37,41,43,5053  Two39,48  of 7 reviews,30,3840,4648  including only observational studies did not adequately assess risk of bias.

Lanigan 200133  and Pinto-Sanchez 201641  had a potential conflict as they were both funded by the baby food company, Nestle Ltd (question #16). Most studies did not report whether the funding sources of included studies was checked (n = 25; question #10).

Thirteen studies conducted meta-analyses. Two32,42  did not use appropriate meta-analysis methods. They either did not investigate causes of heterogeneity or they combined RCT and observational studies within their meta-analysis. Eight of the 13 meta-analyses failed to assess or discuss potential publication bias and the effects on their results (question #15).32,35,36,38,42,49,52,53 

The key findings from the 32 included reviews are summarized by outcome in Table 3 and the reviews cover 10 main outcomes (Supplemental Figure 3). The following sections will describe the findings according to childhood outcome. Areas explored by the included reviews but found to be lacking evidence are in Supplemental Table 11.

TABLE 3

Summary of Findings by Childhood Outcomes

FoodExposure AgeAssociation in ChildhoodCertainty of Effect (GRADE) as Reported in the Highest Quality ReviewsaReviews Reporting Sufficient Evidence
Food allergy Food-specific allergy N = 9/11b 
 Compl. food <4m vs ≥4m None with food allergy Moderate (high quality review) Burgess 2019,31  de Silva 2014,50  Larson 2017,34  Obbagy 2019a25 * 
 Allergenic food 3–6m vs >6m None with food allergy Very low (high quality review) de Silva 202029  
 Egg 3/4–6m vs >6m Decreased risk with cooked egg Moderate (high quality reviews) Al-Saud 2018,49  Burgess 2019,31  Dai 2021,35  de Silva 2020,29 * Ierodiakonou 2016,28 * Larson 2017,34  Obbagy 2019a25 * 
None with raw or pasteurized egg Moderate (high quality review) de Silva 202029  
 Peanut 4–11m vs >11m Decreased risk Moderate to high (high quality reviews) Burgess 2019,31  de Silva 2020,29 * Ierodiakonou 2016,28 * Larson 2017,34  Obbagy 2019a25 * 
 Cow’s milk <4m vs ≥4m None Low (high quality reviews) de Silva 2014,50  Ierodiakonou 2016,28 * Obbagy 2019a25 * 
 Fish ≤9m vs >9m Decreased risk Very lowa (low quality review) Burgess 2019,31 * Larson 201734  
<4m vs ≥4m Decreased risk Very lowa (moderate quality review) de Silva 201450  
 Wheat or gluten <7m vs ≥7m No evidence Very lowa (moderate quality review) Burgess 2019,31  Chmielewska 201751 * 
Food sensitization Food-specific sensitization N = 4/4 
 Compl. food <4m vs ≥4m Increased risk of food sensitization Moderatea (low quality review) Burgess 201931  
 Egg 3/4–6m vs >6m Decreased risk Moderate (moderate quality review) Al-Saud 2018,49 * Burgess 201931  
4-6m vs >6m None Moderate (high quality review) Ierodiakonou 201628  
 Peanut 4–11m vs >11m None Moderate (high quality review) Ierodiakonou 201628  
 Fish ≤6–9m vs >9m Decreased risk Very low (high quality review) Burgess 2019,31  Ierodiakonou 201628 * 
 Wheat or gluten <7m vs ≥7m Decreased risk Very lowa (moderate quality review) Chmielewska 201751  
Asthma    N = 6/6 
 Compl. food <4m vs ≥4m None Moderate (high quality review)) Obbagy 2019a,25 * Tarini 200644  
 Egg ≤6m vs >6m None Very low (high quality review) Al-Saud 2018,49  Obbagy 2019a25 * 
 Peanut, tree nuts, sesame <4m vs ≥4m None Very low (high quality review) Obbagy 2019a25  
 Cow’s milk <4m vs ≥4m None Low (high quality review) Griebler 2015,32  Ierodiakonou 201628 * 
 Fish <8m vs 8–12m Decreased risk of wheeze Low to very low (high quality review) Ierodiakonou 201628  
6–9m vs >9m Decreased risk of wheeze and asthma Lowa (low quality review) Papamichael 201838  
Eczema and atopic dermatitis  N = 6/6 
 Compl. food <4m vs ≥4m None Moderate (high quality review) Obbagy 2019a,25 * Waidyatillake 201836  
Increased risk Very lowa (very low quality review) Tarini 200644  
 Allergenic food <12m vs ≥12 None Very low (high quality review) Ierodiakonou 2016,28 * Waidyatillake 201836  
 Egg ≤4 or ≤6m versus later None Low (high quality review) Al-Saud 2018,49  Obbagy 2019a,25 * Waidyatillake 201836  
 Peanut, tree nuts, seeds 5–11m vs >12 None Very low (high quality review) Obbagy 2019a25  
 Cow’s milk <4m vs ≥4m Decreased risk Very low (very low quality review) Griebler 201532  
5–11m vs >12 None Low to very low (high quality review) Obbagy 2019a,25 * Ierodiakonou 201628 * 
 Fish 5–11m vs >12 Decreased risk Very low (high quality review) Obbagy 2019a25  
Allergic rhinitis   N = 2/4c 
 Fruits, vegetables, and meat 4–11m vs ≥12m None Low (high quality review) Obbagy 2019a25  
 Fish <6–12m vs >12m Decreased risk Low (high quality review) Ierodiakonou 201628  
Celiac disease and autoimmunity  N = 4/4 
 Gluten 4–6m vs >6m None High (moderate quality review) Pinto-Sanchez 2016,41  Silano 2016,43  Szajewska 201553 * 
<12m vs ≥12m None High (high quality review) Ierodiakonou 2016,28 * Silano 2016,43  Szajewska 201553  
Overweight and obesity   N = 7/8d 
 Compl. food <4m vs ≥4m Increased risk Low (high quality review) English 2019a,24* Pearce 2013,40  Wang 2016,46  Weng 2012,47  Woo Baidal 201648  
<6m or ≥6m None Very lowa (low quality review) Araujo 2019,30 * Wang 201646  
<12m vs ≥12m None Very lowa (low quality review) Moorcroft 201137  
 Body wt   N = 3/4e 
 Compl. food <6m vs ≥6m None Moderate (high quality review) English 2019a,24* Qasem 201542  
 Cow’s milk <4m vs ≥4m None Low (very low quality review) Griebler 201532  
Type 1 diabetes   N = 4/4 
 Cow’s milk <4m vs ≥4m None Very low (high quality review) Griebler 2015,32  Ierodiakonou 201628 * 
Increased risk Very lowa (very low quality review) Patelarou 201239  
 Gluten <12m vs ≥12m None Low (high quality review) Ierodiakonou 2016,28 * Piescik-Lech 201752  
<4m vs ≥4m Increased risk Very lowa (moderate quality review) Piescik-Lech 201752  
Iron status    N = 2/2 
 Compl. food 4m vs 6m Decreased risk of iron deficiency and anemia Very lowa (very low quality review) Qasem 201542  
None with iron status Moderate (high quality review) Obbagy 2019c26  
Other disorders   N = 2/4f 
 Allergenic food <12m vs ≥12m None with autoimmune diseases Low (high quality review) Ierodiakonou 201628  
 Cow’s milk <4m vs ≥4m None with gastrointestinal blood loss Very low (very low quality review) Griebler 201532  
FoodExposure AgeAssociation in ChildhoodCertainty of Effect (GRADE) as Reported in the Highest Quality ReviewsaReviews Reporting Sufficient Evidence
Food allergy Food-specific allergy N = 9/11b 
 Compl. food <4m vs ≥4m None with food allergy Moderate (high quality review) Burgess 2019,31  de Silva 2014,50  Larson 2017,34  Obbagy 2019a25 * 
 Allergenic food 3–6m vs >6m None with food allergy Very low (high quality review) de Silva 202029  
 Egg 3/4–6m vs >6m Decreased risk with cooked egg Moderate (high quality reviews) Al-Saud 2018,49  Burgess 2019,31  Dai 2021,35  de Silva 2020,29 * Ierodiakonou 2016,28 * Larson 2017,34  Obbagy 2019a25 * 
None with raw or pasteurized egg Moderate (high quality review) de Silva 202029  
 Peanut 4–11m vs >11m Decreased risk Moderate to high (high quality reviews) Burgess 2019,31  de Silva 2020,29 * Ierodiakonou 2016,28 * Larson 2017,34  Obbagy 2019a25 * 
 Cow’s milk <4m vs ≥4m None Low (high quality reviews) de Silva 2014,50  Ierodiakonou 2016,28 * Obbagy 2019a25 * 
 Fish ≤9m vs >9m Decreased risk Very lowa (low quality review) Burgess 2019,31 * Larson 201734  
<4m vs ≥4m Decreased risk Very lowa (moderate quality review) de Silva 201450  
 Wheat or gluten <7m vs ≥7m No evidence Very lowa (moderate quality review) Burgess 2019,31  Chmielewska 201751 * 
Food sensitization Food-specific sensitization N = 4/4 
 Compl. food <4m vs ≥4m Increased risk of food sensitization Moderatea (low quality review) Burgess 201931  
 Egg 3/4–6m vs >6m Decreased risk Moderate (moderate quality review) Al-Saud 2018,49 * Burgess 201931  
4-6m vs >6m None Moderate (high quality review) Ierodiakonou 201628  
 Peanut 4–11m vs >11m None Moderate (high quality review) Ierodiakonou 201628  
 Fish ≤6–9m vs >9m Decreased risk Very low (high quality review) Burgess 2019,31  Ierodiakonou 201628 * 
 Wheat or gluten <7m vs ≥7m Decreased risk Very lowa (moderate quality review) Chmielewska 201751  
Asthma    N = 6/6 
 Compl. food <4m vs ≥4m None Moderate (high quality review)) Obbagy 2019a,25 * Tarini 200644  
 Egg ≤6m vs >6m None Very low (high quality review) Al-Saud 2018,49  Obbagy 2019a25 * 
 Peanut, tree nuts, sesame <4m vs ≥4m None Very low (high quality review) Obbagy 2019a25  
 Cow’s milk <4m vs ≥4m None Low (high quality review) Griebler 2015,32  Ierodiakonou 201628 * 
 Fish <8m vs 8–12m Decreased risk of wheeze Low to very low (high quality review) Ierodiakonou 201628  
6–9m vs >9m Decreased risk of wheeze and asthma Lowa (low quality review) Papamichael 201838  
Eczema and atopic dermatitis  N = 6/6 
 Compl. food <4m vs ≥4m None Moderate (high quality review) Obbagy 2019a,25 * Waidyatillake 201836  
Increased risk Very lowa (very low quality review) Tarini 200644  
 Allergenic food <12m vs ≥12 None Very low (high quality review) Ierodiakonou 2016,28 * Waidyatillake 201836  
 Egg ≤4 or ≤6m versus later None Low (high quality review) Al-Saud 2018,49  Obbagy 2019a,25 * Waidyatillake 201836  
 Peanut, tree nuts, seeds 5–11m vs >12 None Very low (high quality review) Obbagy 2019a25  
 Cow’s milk <4m vs ≥4m Decreased risk Very low (very low quality review) Griebler 201532  
5–11m vs >12 None Low to very low (high quality review) Obbagy 2019a,25 * Ierodiakonou 201628 * 
 Fish 5–11m vs >12 Decreased risk Very low (high quality review) Obbagy 2019a25  
Allergic rhinitis   N = 2/4c 
 Fruits, vegetables, and meat 4–11m vs ≥12m None Low (high quality review) Obbagy 2019a25  
 Fish <6–12m vs >12m Decreased risk Low (high quality review) Ierodiakonou 201628  
Celiac disease and autoimmunity  N = 4/4 
 Gluten 4–6m vs >6m None High (moderate quality review) Pinto-Sanchez 2016,41  Silano 2016,43  Szajewska 201553 * 
<12m vs ≥12m None High (high quality review) Ierodiakonou 2016,28 * Silano 2016,43  Szajewska 201553  
Overweight and obesity   N = 7/8d 
 Compl. food <4m vs ≥4m Increased risk Low (high quality review) English 2019a,24* Pearce 2013,40  Wang 2016,46  Weng 2012,47  Woo Baidal 201648  
<6m or ≥6m None Very lowa (low quality review) Araujo 2019,30 * Wang 201646  
<12m vs ≥12m None Very lowa (low quality review) Moorcroft 201137  
 Body wt   N = 3/4e 
 Compl. food <6m vs ≥6m None Moderate (high quality review) English 2019a,24* Qasem 201542  
 Cow’s milk <4m vs ≥4m None Low (very low quality review) Griebler 201532  
Type 1 diabetes   N = 4/4 
 Cow’s milk <4m vs ≥4m None Very low (high quality review) Griebler 2015,32  Ierodiakonou 201628 * 
Increased risk Very lowa (very low quality review) Patelarou 201239  
 Gluten <12m vs ≥12m None Low (high quality review) Ierodiakonou 2016,28 * Piescik-Lech 201752  
<4m vs ≥4m Increased risk Very lowa (moderate quality review) Piescik-Lech 201752  
Iron status    N = 2/2 
 Compl. food 4m vs 6m Decreased risk of iron deficiency and anemia Very lowa (very low quality review) Qasem 201542  
None with iron status Moderate (high quality review) Obbagy 2019c26  
Other disorders   N = 2/4f 
 Allergenic food <12m vs ≥12m None with autoimmune diseases Low (high quality review) Ierodiakonou 201628  
 Cow’s milk <4m vs ≥4m None with gastrointestinal blood loss Very low (very low quality review) Griebler 201532  

N, reviews that reported sufficient evidence. M, months. Compl. food, complementary food (liquids, semisolids, and solids other than breastmilk or infant formula, unless specified).

a

GRADE certainty of evidence as reported by the systematic review with the highest AMSTAR 2 quality, except for these outcomes missing GRADES where overview authors assessed GRADE.

b

Insufficient food allergy evidence in Tarini 200644  and Thompson 2010.45 

c

Insufficient allergic rhinitis evidence in Al-Saud 201849  and Tarini 2006.44 

d

Insufficient obesity evidence in Vissers 2018.22 

e

Insufficient body wt and growth evidence in Lanigan 2001.33 

f

Insufficient evidence in Griebler 201532  and English 2019b.24 

*

Highest quality review.

Food Allergy and Sensitization

Eleven of the 32 included reviews investigated food sensitization and/or food allergy as an outcome. Four reviews agreed there was moderate quality evidence to support no association between general complementary food and food allergy later in life. Burgess 201931  was the only food allergy review which performed meta-analyses. Authors found that introduction of complementary food at or after 4 months increased the likelihood of food sensitization compared with before 4 months. However, their meta-analysis only included 3 cohorts. The other 21 original studies were lacking the correct exposure or outcome data.

Eight reviews examined the exposure to individual foods, such as peanut, egg, milk, and wheat, and food allergy outcomes. Ierodiakonou 2016 was the highest quality meta-analysis conducted on early egg (6 RCTs), peanut (2 RCTs), and milk (2 RCTs) introduction in association with egg, peanut, and milk allergy, respectively. The more recent Obbagy 2019a25  presented consistent findings without a meta-analysis. De Silva 202029  and Dai 202135  did not find any additional original studies (Supplemental Table 8).

Two reviews44,45  conducted before 2015 (when an RCT showing peanut introduction prevented peanut allergy was published54 ) indicated insufficient evidence for food allergy. After 2015, there was moderate to high certainty evidence from high quality reviews that peanut introduction between 4 and 11 months was protective of peanut allergy (n = 5 reviews, 2 RCTs), and egg introduction between 4 and 6 months was protective of egg allergy (n = 6 reviews, 6 RCTs). There was consensus between reviews that age of cow’s milk (n = 3) and wheat introduction (n = 2) was not associated with milk or wheat allergy, respectively, although the evidence was low to very low, from few, mostly observational studies.

Asthma

Six reviews reported asthma outcomes. Four of them found no association between age of introduction of complementary food, cow’s milk, egg, peanut, tree nuts, or sesame in the first year of life and asthma later in life, although the certainty of the evidence for the allergenic foods was low to very low. Ierodiakonou 201628  and Papamichael 201838  found a decreased risk of current wheeze and asthma in children under 4 years old who had been introduced to fish and eaten frequently (at least weekly) from 6 to 9 months of age in meta-analyses of 11 RCTs and 3 cohorts, respectively.28,38 

Eczema or Atopic Dermatitis

Four25,28,36,49  of 6 reviews that assessed eczema found no association between age of introduction of complementary food or allergenic food introduction and eczema. Griebler 201532  and Tarini 200644  (very low confidence reviews) found very low certainty evidence linking introduction of cow’s milk by age 1 and eczema and the introduction of complementary food before 4 months and eczema. A high quality review25  in 2019 did not support earlier findings indicating there was moderate certainty evidence of no effect. Authors found limited evidence that introduction of fish from 5 to 11 months, compared with delaying until 1 year, may reduce risk of atopic dermatitis. Though evidence was conflicting, most studies reported that age of introduction of complementary or allergenic foods did not affect eczema outcomes.

Allergic Rhinitis

Ierodiakonou 201628  found that fish introduction before 6 months versus 6 to 12 months decreased the risk of allergic rhinoconjunctivitis. The authors indicated the evidence was low certainty from 4 prospective cohort studies with high heterogeneity (I2 = 59.2%).28  Obbagy 2019a25  determined there was low certainty evidence supporting no effect of introduction of fish, vegetables, and meat on allergic rhinitis, but there was not enough evidence for other foods. Two other reviews44,49  found insufficient evidence on the association between any food introduction and allergic rhinitis.

Celiac Disease

Three28,43,53  of 4 reviews presented high certainty evidence that introduction of gluten or wheat products before age 1 was not associated with developing celiac disease or autoimmunity later in life. Contrarily, Pinto-Sanchez 201641  (low confidence review) reported gluten introduction past 6 months could increase the risk of celiac disease compared with earlier. This data were from 5 cohort studies (n = 100 224 participants), whereas data from Szajewska 201553  and Ierodiakonou 201628  was based on RCT data (4 RCTs; n = 1822).

Obesity and Overweight

Three reviews found low to very low certainty evidence that introduction of complementary food from 4 months onwards was not associated with overweight or obesity. Five reviews found low certainty evidence that introducing complementary food before 4 months could increase the risk of overweight and obesity in childhood and adolescence.27,40,4648  English 2019a27  (the highest quality review) included 2 RCTs and 71 prospective cohort studies to support this finding. Wang 201646  performed a meta-analysis of eight studies on overweight and 5 studies on obesity, but heterogeneity was moderate to high and the review itself was low quality. Authors found an overall risk ratio of 1.18 (95% confidence interval [CI], 1.06–1.31) for risk of overweight and 1.33 (95% CI, 1.07–1.64) for risk of obesity if complementary food were introduced before 4 months compared with later.46  One review found insufficient evidence on the introduction of complementary foods in preterm infants and obesity outcomes.22  No systematic reviews examined the association between age at introduction of allergenic foods and risk of overweight or obesity.

Body Weight

Four reviews27,32,33,42  presented data on the introduction of complementary food or cow’s milk on childhood weight and growth (weight, height, BMI, etc.), rather than the searched terms for obesity and underweight. None reported an association. Lanigan33  found insufficient evidence on the topic in 2001. Later reviews27,32,42  provided low to moderate evidence that age of introduction of complementary food or cow’s milk has no effect on growth outcomes.

Type 1 Diabetes Mellitus

Four reviews examined the association between timing of introduction of cow’s milk28,32,39  (n = 3) or gluten28,52  (n = 2) and type 1 diabetes. Patelarou 201239  reported an increased risk of type 1 diabetes in infants introduced to cow’s milk early (“early” age: by 3, 5, or 7 months, versus later), however the data were inconsistent and very low certainty (n = 6 observational studies). Piescik-Lech 201752  found very low certainty evidence (n = 2 observational studies) that gluten introduction before 4 months may increase the risk of type 1 diabetes later in life. Ierodiakonou 201628  (high-quality review) did not find any effect of age of cow’s milk introduction or gluten on type 1 diabetes.

Iron Deficiency and Anemia

Two reviews examined iron deficiency and/or anemia.26,42  Qasem 201642  found very low certainty evidence that introducing complementary food at 4 months compared with 6 months could increase hemoglobin status (1 RCT) in developing countries (mean difference, 5.0g/L; 95% CI, 1.5–8.5g/L; P = .005) and plasma ferritin concentration (2 RCTs) in both developing (P = .050) and developed (P = .040) countries. However, a higher quality review26  in 2019 found moderate certainty evidence of no association with iron status in childhood.

Other Health Outcomes

Two reviews examine a variety of other health outcomes in relation to age of introduction of complementary food, cow’s milk, or other allergenic foods.28,32  Griebler 201632  found very low certainty evidence of no association between introduction of cow’s milk and gastrointestinal blood loss (3 non-RCTs, 1 cohort). There was insufficient evidence to examine the effect of age of introduction of cow’s milk and dehydration or gastrointestinal diseases. Ierodiakonou 201628  found that age of introduction of allergenic solids by age 1 was not associated with the risk of a range of autoimmune diseases (eg, inflammatory bowel disease, autoimmune thyroid disease, and juvenile rheumatoid arthritis), from 48 observational studies.

Two studies determined there was insufficient evidence on bone health or osteoporosis.23,32  No reviews were found on the outcomes: eosinophilic esophagitis, pernicious anemia, diabetes type 2, dental caries, neurodevelopment, cardiovascular disease, respiratory tract infection, or diarrhea.

Overall, there was evidence to support that introduction of complementary and allergenic solids in the first year of life, from around 6 months of age, was safe for a range of health outcomes. We found 19 of the systematic reviews covered food allergy or obesity. There was high certainty RCT evidence that the introduction of peanut and egg in the first year of life reduces the risk of peanut and egg allergy, respectively. Infants who are introduced to complementary food before 4 months may have a higher risk of overweight and obesity, though reviews including alternate growth outcomes did not see an effect. There was no evidence introduction of gluten was associated to celiac disease, supporting the fact that the immunologic pathway is different in celiac disease than in food allergies.

The evidence supporting allergen introduction for the prevention of food allergy was based on RCTs of peanut or egg. All 5 reviews for peanut are based on the same 2 RCTs from primarily Caucasian, high-income countries.54,55  Therefore, the ability to extrapolate the findings to different populations is limited. More original research is required for cow’s milk, tree nuts, sesame, and shellfish.

Reviews on obesity examined a range of food as exposures, but not allergenic foods specifically. The finding that food introduction before 4 months may increase the risk of obesity should be examined with caution. Most reviews agreed that results were of low certainty and may be biased. Early interest in food could be a marker for genetic susceptibility to increased appetite or hormonal pathways which increase the risk of obesity.56  Early feeding by parents may indicate a family dynamic and environment that promotes eating larger portions and leads to obesity.57 

The WHO recommends a varied diet including “meat, poultry, fish or eggs, as well as vitamin-A rich fruits and vegetables”7  from 6 to 24 months, while continuing to breastfeed. Nutritionally, the types of food introduced may affect some health outcomes more than the timing. Iron-rich foods in infancy prevent iron deficiency in breastfed infants.26  To the contrary, sugar-sweetened drinks may increase the likelihood of obesity in childhood.58 

Parents can get stressed and overwhelmed during the weaning period (when transitioning infants to a solid diet).59  Some families note that changing and conflicting advice can lack practical suggestions and make this time more difficult.59  Some health professionals now recommend weaning infants when they are “developmentally ready,” rather than at a specific age. One systematic review found that baby led weaning could have growth, health, and developmental benefits, though the original articles define baby led weaning inconsistently, with a potentially biased methodology.60  Contrarily, delaying the introduction of “lumpy” foods until too late could lead to feeding problems later in childhood.61 

Most infant feeding guidelines recommend beginning introducing complementary food to a child’s diet around 6 months of age (eg, WHO, Europe, US, Australia).7,12,13,62  This overview has found evidence to support 6 months as a safe age to introduce foods. Interestingly, WHO, European, and Australian general infant feeding guidelines do not include recommendations on how or when to introduce allergenic solids, even though there is now considerable evidence that this could prevent food allergy.1517  Furthermore, earlier allergen introduction has not been found to have a negative effect on breastfeeding rates in trials or in population-based studies.55,63 

There is a lack of evidence between complementary or allergenic food and bone health, iron deficiency, gastrointestinal diseases, autoimmune disorders, asthma, eczema, or allergic rhinitis. Evidence was very low regarding cow’s milk or wheat introduction and milk or wheat allergy, respectively.

The introduction of fish around 6 months compared with later may prevent asthma and allergic rhinitis in childhood, however the quality of evidence is limited and conflicting. This association may be because of omega-3 fatty acid, which has been linked to protection from asthma in an RCT.64  There was low certainty evidence supporting no effect of introduction of fish, vegetables, and meat on allergic rhinitis, but not enough evidence for other foods.25 

The data available for overweight and obesity and type 1 diabetes were low certainty. Preterm infants are a group of interest for obesity prevention, however the only review to examine this topic found insufficient evidence.22  There were no systematic reviews examining the effect of age at introduction of allergenic foods and risk of overweight or obesity.

No reviews were found on timing of any food introduction and: eosinophilic esophagitis, pernicious anemia, diabetes type 2, dental caries, neurodevelopment, cardiovascular disease, respiratory tract infection, or diarrhea.

A strength of the current overview is that we followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We have collated systematic reviews to obtain the highest quality data available to date on age of food introduction to infants. Conducting an overview decreases bias in the results, whereas identifying large gaps in infant feeding research. Observational studies were very common, likely because it would be unethical to randomize complementary food introduction to infants outside of the recommended age bracket of 4 to 6 months. Over 410 original papers were included within the 32 reviews.

A potential limitation was not including gray literature because we were interested in reviews that had undergone peer review, however we did hand search government documents for systematic reviews. Because only 1 review focused on preterm infants, we are not able to extrapolate out findings to this subgroup of infants. Further research into preterm infants would be warranted because preterm infants being highly susceptible to health problems. This overview depends on the quality of the included reviews, so under-researched topics may not have a systematic review published yet.

This review supports current recommendations to introduce complementary and allergenic solids by age 1, from around 6 months of age, as it seems safe for a range of childhood health outcomes. Nevertheless, infant food introduction may occur at different ages for a variety of complex reasons. Complementary feeding is influenced by a range of socioeconomic and cultural factors, so there is unlikely a “1-size fits all” solution to feeding methods. There is a need to provide higher quality evidence from original studies and systematic reviews regarding introduction of allergenic foods and the outcomes of asthma, eczema, and allergic rhinitis. Original studies are also needed to examine the effect of complementary or allergenic foods on bone health, iron deficiency, gastrointestinal diseases, or other autoimmune disorders.

We thank the librarian Ms. Poh Chua from the Royal Children’s Hospital Library for assistance with the search strategy and Prof. Anne-Louise Ponsonby for her support as a PhD supervisor to V.X.S.

Dr Soriano conceptualized and designed the study, performed data screening and extraction, conducted the initial analyses, drafted the initial manuscript, and reviewed and revised the manuscript; Ms Ciciulla, Ms Gell, and Dr Wang performed data screening, data extraction, and critically reviewed the manuscript for important intellectual content; Drs Peters, McWilliam, Dharmage, and Koplin supervised the conceptualization and design of the study, interpretation of results, and critically reviewed the manuscript for important intellectual content; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

FUNDING: Research at the Murdoch Children’s Research Institute is supported by the Victorian Government’s Operational Infrastructure Program. Dr Soriano was supported by a PhD scholarship from the National Health and Medical Research Council-funded Centre for Food and Allergy Research (CFAR; GNT1134812). Drs Peters (GNT1160779), Dharmage, and Koplin (GNT1158699) are supported by National Health and Medical Research Council-funded fellowships. Dr McWilliam is supported by a Melbourne Children’s Clinician-Scientist Fellowship. The funders and sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Sponsors did not have the right to veto publication or to control the decision regarding to which journal the paper was submitted.

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this article to disclose.

AMSTAR

A Measurement Tool to Assess Systematic Reviews

RCT

randomized controlled trial

WHO

World Health Organization

1
WHO
.
The optimal duration of exclusive breastfeeding. Report of an expert consultation
. In:
Nutrition for Health and Development CaAHaD, ed
.
Geneva, Switzerland
:
World Health Organization
;
2001
2
Horta
BL
,
Victora
CG
,
World Health Organization
.
Short-term Effects of Breastfeeding: a Systematic Review on the Benefits of Breastfeeding on Diarrhoea and Pneumonia Mortality
.
Geneva, Switzerland
:
World Health Organization
;
2013
3
Victora
CG
,
Bahl
R
,
Barros
AJD
, et al;
Lancet Breastfeeding Series Group
.
Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect
.
Lancet
.
2016
;
387
(
10017
):
475
490
4
Trumbo
P
,
Schlicker
S
,
Yates
AA
,
Poos
M
;
Food and Nutrition Board of the Institute of Medicine, The National Academies
.
Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids
.
J Am Diet Assoc
.
2002
;
102
(
11
):
1621
1630
5
Naylor
A
,
Morrow
A
, eds.
Developmental Readiness of Normal Full Term Infants to Progress From Exclusive Breastfeeding to the Introduction of Complementary Foods: Reviews of the Relevant Literature Concerning Infant Immunologic, Gastrointestinal, Oral Motor and Maternal Reproductive and Lactational Development
.
Washington, D.C
:
Wellstart International and the LINKAGES Project/ Academy for Educational Development
;
2001
6
Parenting UNICEF
.
Feeding Your Baby: 6–12 Months
.
New York, NY
:
UNICEF
;
2022
7
WHO
.
Complementary feeding: report of the global consultation, and summary of guiding principles for complementary feeding of the breastfed child
. In:
Development DoCaAHa, Development DoNfHa, eds
.
Geneva, Switzerland
:
World Health Organization
;
2003
8
Bailey
RL
,
Catellier
DJ
,
Jun
S
, et al
.
Total usual nutrient intakes of US children (under 48 months): findings from the feeding infants and toddlers study (FITS) 2016
.
J Nutr
.
2018
;
148
(
9S 9s
):
1557S
1566S
9
UNSCN
.
Non-communicable diseases, diets, and nutrition
.
Available at: www.unscn.org: Accessed October 28, 2021
10
McKenzie
C
,
Tan
J
,
Macia
L
,
Mackay
CR
.
The nutrition-gut microbiome-physiology axis and allergic diseases
.
Immunol Rev
.
2017
;
278
(
1
):
277
295
11
Vale
SL
,
Lobb
M
,
Netting
MJ
, et al
.
A systematic review of infant feeding food allergy prevention guidelines - can we AGREE?
World Allergy Organ J
.
2021
;
14
(
6
):
100550
12
Fewtrell
M
,
Bronsky
J
,
Campoy
C
, et al
.
Complementary feeding: a position paper by the European society for paediatric gastroenterology, hepatology, and nutrition (ESPGHAN) committee on nutrition
.
J Pediatr Gastroenterol Nutr
.
2017
;
64
(
1
):
119
132
13
Dietary Guidelines for Americans
.
2020-2025 Make Every Bite Count With the Dietary Guidelines
, 9th ed.
Washington, D.C.
:
USDA and DHHS
;
2020
14
NHMRC
.
Infant Feeding Guidelines: Summary
.
Canberra, Australia
:
National Health and Medical Research Council
;
2013
15
Australasian Society of Clinical Immunology and Allergy
.
Infant feeding and allergy prevention
.
16
Halken
S
,
Muraro
A
,
de Silva
D
, et al;
European Academy of Allergy and Clinical Immunology Food Allergy and Anaphylaxis Guidelines Group
.
EAACI guideline: preventing the development of food allergy in infants and young children (2020 update)
.
Pediatr Allergy Immunol
.
2021
;
32
(
5
):
843
858
17
Fleischer
DM
,
Chan
ES
,
Venter
C
, et al
.
A consensus approach to the primary prevention of food allergy through nutrition: guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology
.
J Allergy Clin Immunol Pract
.
2021
;
9
(
1
):
22
43.e4
18
Shamseer
L
,
Moher
D
,
Clarke
M
, et al;
PRISMA-P Group
.
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
.
BMJ
.
2015
;
350
:
g7647
g7647
19
Bougioukas
KI
,
Liakos
A
,
Tsapas
A
,
Ntzani
E
,
Haidich
A-B
.
Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms
.
J Clin Epidemiol
.
2018
;
93
:
9
24
20
Higgins
JPT
,
Thomas
J
,
Chandler
J
, et al
.
Cochrane Handbook for Systematic Reviews of Interventions Version 6.0
.
Chichester, UK
:
John Wiley & Sons, Ltd
;
2019
21
Shea
BJ
,
Reeves
BC
,
Wells
G
, et al
.
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
.
BMJ
.
2017
;
358
:
j4008
22
Vissers
KM
,
Feskens
EJM
,
van Goudoever
JB
,
Janse
AJ
.
The timing of initiating complementary feeding in preterm infants and its effect on overweight: a systematic review
.
Ann Nutr Metab
.
2018
;
72
(
4
):
307
315
23
Obbagy
JE
,
English
LK
,
Wong
YP
, et al
.
Complementary feeding and bone health: a systematic review
.
Am J Clin Nutr
.
2019b
;
109
(
Suppl_7
):
872S
878S
24
English
LK
,
Obbagy
JE
,
Wong
YP
, et al
.
Complementary feeding and developmental milestones: a systematic review
.
Am J Clin Nutr
.
2019b
;
109
(
Suppl_7
):
879S
889S
25
Obbagy
JE
,
English
LK
,
Wong
YP
, et al
.
Complementary feeding and food allergy, atopic dermatitis/eczema, asthma, and allergic rhinitis: a systematic review
.
Am J Clin Nutr
.
2019a
;
109
(
Suppl_7
):
890S
934S
26
Obbagy
JE
,
English
LK
,
Psota
TL
, et al
.
Complementary feeding and micronutrient status: a systematic review
.
Am J Clin Nutr
.
2019c
;
109
(
Suppl_7
):
852S
871S
27
English
LK
,
Obbagy
JE
,
Wong
YP
, et al
.
Timing of introduction of complementary foods and beverages and growth, size, and body composition: a systematic review
.
Am J Clin Nutr
.
2019a
;
109
(
Suppl_7
):
935S
955S
28
Ierodiakonou
D
,
Garcia-Larsen
V
,
Logan
A
, et al
.
Timing of allergenic food introduction to the infant diet and risk of allergic or autoimmune disease: a systematic review and meta-analysis
.
JAMA
.
2016
;
316
(
11
):
1181
1192
29
de Silva
D
,
Halken
S
,
Singh
C
, et al;
European Academy of Allergy, Clinical Immunology Food Allergy, Anaphylaxis Guidelines Group
.
Preventing food allergy in infancy and childhood: systematic review of randomised controlled trials
.
Pediatr Allergy Immunol
.
2020
;
31
(
7
):
813
826
30
Araújo
CS
,
de Farias Costa
PR
,
de Oliveira Queiroz
VA
, et al
.
Age of introduction of complementary feeding and overweight in adolescence and adulthood: a systematic review
.
Matern Child Nutr
.
2019
;
15
(
3
):
e12796
31
Burgess
JA
,
Dharmage
SC
,
Allen
K
, et al
.
Age at introduction to complementary solid food and food allergy and sensitization: a systematic review and meta-analysis
.
Clin Exp Allergy
.
2019
;
49
(
6
):
754
769
32
Griebler
U
,
Bruckmüller
MU
,
Kien
C
, et al
.
Health effects of cow’s milk consumption in infants up to 3 years of age: a systematic review and meta-analysis
.
Public Health Nutr
.
2016
;
19
(
2
):
293
307
33
Lanigan
JA
,
Bishop
J
,
Kimber
AC
, %
Morgan
J
.
Systematic review concerning the age of introduction of complementary foods to the healthy full-term infant
.
Eur J Clin Nutr
.
2001
;
55
(
5
):
309
320
34
Larson
K
,
McLaughlin
J
,
Stonehouse
M
,
Young
B
,
Haglund
K
.
Introducing allergenic food into infants’ diets: systematic review
.
MCN Am J Matern Child Nurs
.
2017
;
42
(
2
):
72
80
35
Dai
NN
,
Li
XY
,
Wang
S
,
Wang
JJ
,
Gao
YJ
,
Li
ZL
.
[Timing of food introduction to the infant diet and risk of food allergy: a systematic review and Meta-analysis]
.
Zhonghua Er Ke Za Zhi
.
2021
;
59
(
7
):
563
569
36
Waidyatillake
NT
,
Dharmage
SC
,
Allen
KJ
, et al
.
Association between the age of solid food introduction and eczema: a systematic review and a meta-analysis
.
Clin Exp Allergy
.
2018
;
48
(
8
):
1000
1015
37
Moorcroft
KE
,
Marshall
JL
,
McCormick
FM
.
Association between timing of introducing solid foods and obesity in infancy and childhood: a systematic review
.
Matern Child Nutr
.
2011
;
7
(
1
):
3
26
38
Papamichael
MM
,
Shrestha
SK
,
Itsiopoulos
C
,
Erbas
B
.
The role of fish intake on asthma in children: a meta-analysis of observational studies
.
Pediatr Allergy Immunol
.
2018
;
29
(
4
):
350
360
39
Patelarou
E
,
Girvalaki
C
,
Brokalaki
H
, %
Patelarou
A
,
Androulaki
Z
,
Vardavas
C
.
Current evidence on the associations of breastfeeding, infant formula, and cow’s milk introduction with type 1 diabetes mellitus: a systematic review
.
Nutr Rev
.
2012
;
70
(
9
):
509
519
40
Pearce
J
,
Taylor
MA
,
Langley-Evans
SC
.
Timing of the introduction of complementary feeding and risk of childhood obesity: a systematic review
.
Int J Obes (Lond)
.
2013
;
37
(
10
):
1295
1306
41
Pinto-Sánchez
MI
,
Verdu
EF
,
Liu
E
, et al
.
Gluten introduction to infant feeding and risk of celiac disease: systematic review and meta-analysis
.
J Pediatr
.
2016
;
168
:
132
143.e3
42
Qasem
W
,
Fenton
T
,
Friel
J
.
Age of introduction of first complementary feeding for infants: a systematic review
.
BMC Pediatrics
.
2015
;
15
(
1
):
107
43
Silano
M
,
Agostoni
C
,
Sanz
Y
,
Guandalini
S
.
Infant feeding and risk of developing celiac disease: a systematic review
.
BMJ Open
.
2016
;
6
(
1
):
e009163
44
Tarini
BA
,
Carroll
AE
,
Sox
CM
,
Christakis
DA
.
Systematic review of the relationship between early introduction of solid foods to infants and the development of allergic disease
.
Arch Pediatr Adolesc Med
.
2006
;
160
(
5
):
502
507
45
Thompson
RL
,
Miles
LM
,
Lunn
J
, et al
.
Peanut sensitisation and allergy: influence of early life exposure to peanuts
.
Br J Nutr
.
2010
;
103
(
9
):
1278
1286
46
Wang
J
,
Wu
Y
,
Xiong
G
, et al
.
Introduction of complementary feeding before 4 months of age increases the risk of childhood overweight or obesity: a meta-analysis of prospective cohort studies
.
Nutr Res
.
2016
;
36
(
8
):
759
770
47
Weng
SF
,
Redsell
SA
,
Swift
JA
,
Yang
M
,
Glazebrook
CP
.
Systematic review and meta-analyses of risk factors for childhood overweight identifiable during infancy
.
Arch Dis Child
.
2012
;
97
(
12
):
1019
1026
48
Woo Baidal
JA
,
Locks
LM
,
Cheng
ER
,
Blake-Lamb
TL
,
Perkins
ME
,
Taveras
EM
.
Risk factors for childhood obesity in the first 1,000 days: a systematic review
.
Am J Prev Med
.
2016
;
50
(
6
):
761
779
49
Al-Saud
B
,
Sigurdardóttir
ST
.
Early introduction of egg and the development of egg allergy in children: a systematic review and meta-analysis
.
Int Arch Allergy Immunol
.
2018
;
177
(
4
):
350
359
50
de Silva
D
,
Geromi
M
,
Halken
S
, et al;
EAACI Food Allergy and Anaphylaxis Guidelines Group
.
Primary prevention of food allergy in children and adults: systematic review
.
Allergy
.
2014
;
69
(
5
):
581
589
51
Chmielewska
A
,
Pieścik-Lech
M
,
Shamir
R
,
Szajewska
H
.
Systematic review: early infant feeding practices and the risk of wheat allergy
.
J Paediatr Child Health
.
2017
;
53
(
9
):
889
896
52
Pieścik-Lech
M
,
Chmielewska
A
,
Shamir
R
,
Szajewska
H
.
Systematic review: early infant feeding and the risk of type 1 diabetes
.
J Pediatr Gastroenterol Nutr
.
2017
;
64
(
3
):
454
459
53
Szajewska
H
,
Shamir
R
,
Chmielewska
A
, et al;
PREVENTCD Study Group
.
Systematic review with meta-analysis: early infant feeding and coeliac disease--update 2015
.
Aliment Pharmacol Ther
.
2015
;
41
(
11
):
1038
1054
54
Du Toit
G
,
Roberts
G
,
Sayre
PH
, et al;
LEAP Study Team
.
Randomized trial of peanut consumption in infants at risk for peanut allergy
.
N Engl J Med
.
2015
;
372
(
9
):
803
813
55
Perkin
MR
,
Logan
K
,
Tseng
A
, et al;
EAT Study Team
.
Randomized trial of introduction of allergenic foods in breast-fed infants
.
N Engl J Med
.
2016
;
374
(
18
):
1733
1743
56
Loos
RJF
,
Yeo
GSH
.
The genetics of obesity: from discovery to biology
.
Nat Rev Genet
.
2021
;
23
(
2
):
120
133
57
Sahoo
K
,
Sahoo
B
,
Choudhury
AK
,
Sofi
NY
,
Kumar
R
,
Bhadoria
AS
.
Childhood obesity: causes and consequences
.
J Family Med Prim Care
.
2015
;
4
(
2
):
187
192
58
English
LK
,
Obbagy
JE
,
Wong
YP
, et al
.
Types and amounts of complementary foods and beverages consumed and growth, size, and body composition: a systematic review
.
Am J Clin Nutr
.
2019c
;
109
(
Suppl_7
):
956S
977S
59
Tully
L
,
Allen-Walker
V
,
Spyreli
E
, et al
.
Solid advice: complementary feeding experiences among disadvantaged parents in two countries
.
Matern Child Nutr
.
2019
;
15
(
3
):
e12801
60
Boswell
N
.
Complementary feeding methods-a review of the benefits and risks
.
Int J Environ Res Public Health
.
2021
;
18
(
13
):
7165
61
Coulthard
H
,
Harris
G
,
Emmett
P
.
Delayed introduction of lumpy foods to children during the complementary feeding period affects child’s food acceptance and feeding at 7 years of age
.
Matern Child Nutr
.
2009
;
5
(
1
):
75
85
62
National Health and Medical Research Council
.
Infant feeding guidelines. Information for health workers (amendments added 2015)
.
63
Koplin
J
,
Soriano
V
,
Netting
M
,
Peters
R
.
Infant feeding patterns before and after changes to food allergy prevention guidelines in Australia
.
Med J Aust
.
2022
;
217
(
4
):
210
211
64
Hansen
S
,
Strøm
M
,
Maslova
E
, et al
.
Fish oil supplementation during pregnancy and allergic respiratory disease in the adult offspring
.
J Allergy Clin Immunol
.
2017
;
139
(
1
):
104
111.e4
65
Guyatt
GH
,
Oxman
AD
,
Vist
GE
, et al;
GRADE Working Group
.
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
.
BMJ
.
2008
;
336
(
7650
):
924
926

Supplementary data